One Team. More Solutions.

Working together to reveal more genomic variations that matter in cancer research.

We’re on a mission to transform the way the world sees the genome. By combining the best-in-class analysis software of BioDiscovery with the structural variant detection power of optical genome mapping, we’re equipping cancer researchers with better tools, expanded services and an expert team. Let’s solve the complexities of cancer together to elevate the health and wellness of all people.

Visit the Bionano booth in the Exhibit Hall to see our solutions for cancer research

One company working together to transform the way the world sees the genome

Finding Community and Connection at CGC

Child cancer patient

Unraveling the Genomics of Cancer

As part of our mission to elevate the health and wellness of all people, Bionano Genomics takes the fight against cancer personally. We’re committed to playing an important role in service to the cancer research community — building better tools, asking harder questions, and working together to make genomic discoveries that can ultimately lead to better outcomes for people diagnosed with cancer.

Innovative Cancer Science

Hosted Panel Session:
Optical Genome Mapping and Its Integration with NGS for Clinical Research in Leukemia and Lymphoma
Tuesday, August 2
4:45 PM – 5:30 PM (CT)
General Session Room

Bionano Genomics will host a panel discussion around the utility of optical genome mapping in clinical research. Dr. Alka Chaubey and a panel of key opinion leaders will discuss the latest results, publications, clinical research, and laboratory implementation. Topics will range from implementation as an alternative to cytogenetics and cytogenomics to the complementarity to NGS and its utility for HRD scoring.


Alka Chaubey
Alka Chaubey


Ravindra Kohle
Ravindra Kolhe
MD, PhD, FCAP Augusta University
Yassmine Akkari
Yassmine Akkari
PhD, FACMG Legacy Health
Rashmi Kanagal-Shamanna
Rashmi Kanagal-Shamanna
MD, MD Anderson Cancer Center
Brynn Levy
Brynn Levy
MSc(Med), PhD, FACMG Columbia University Medical Center & the New York Presbyterian Hospital

Highlighted Scientific Sessions

Sunday, July 31
1:15 PM - 2:20 PM (CT)
Integrating Novel Genomic Alterations for Pathologic Classification and Clinical Risk Assessment in Pediatric and Adult LeukemiasHomologous Recombination DNA Repair Deficiency in Hematological MalignanciesHa Nguyen
MD Anderson Cancer Center, School of Health Professions
Monday, August 1
8:00 AM - 9:00 AM (CT)
SESSION 5TitleAuthors
Implementation of New and Emerging Technologies in Oncologic Laboratories for Improving Patient CareInternational Working Group Recommendations for the Implementation of Optical Genome Mapping in Hematologic MalignanciesAdam Smith
University Health Network
2:15 PM - 3:15 PM (CT)
Application of High-Depth and Novel Genomic Testing Methodologies in the Comprehensive Analyses of Vascular Anomalies and Somatic Mosaic DisordersIdentification of Novel Genomic Structural Variations In Angiosarcoma by Optical Genome MappingThuy Phung
University of South Alabama
Tuesday, August 2
12:50 PM - 2:00 PM (CT)
Roundtable DiscussionDetection of Gene Rearrangements by Next Generation Sequencing (NGS) and Optical Genome MappingPanel
3:00 PM - 4:00 PM (CT)
Expanded Horizons in Hematologic Malignancies: Clonal Behaviors and Novel Genomic ApproachesOptical Genome Mapping and 523-Gene Sequencing Panel for Comprehensive Genomic Evaluation of Myeloid CancersNikhil Sahajpal
Augusta University

Beer, Barbeque, Baseball, and Bionano

Join Us
Tuesday, August 2
6:30 - 9:30 PM (CT)
Salt and Smoke in Ballpark Village

All CGC attendees and their guests are invited to join us Tuesday evening, August 2 at Salt and Smoke in Ballpark Village, overlooking Busch Stadium.
We’ll be reconnecting with colleagues, watching the Cardinals play the Cubs from the patio, and hitting the dance floor with a live DJ. The party starts at 6:30 pm. No RSVP required. Join us!

Decoding Cancer Complexity

Tools for analysis of detected genomic scars associated with homologous recombination deficiency (HRD) continue to evolve. Don’t miss Dr. Soheil Shams’ scientific presentation detailing the development of new genomic scar analysis.

The latest NxClinical software 6.2 release adds three measures of genomic instability for homologous recombination repair deficiency (HRD) in solid tumors:

  • Loss of Heterozygosity (LOH)
  • Telomeric Allelic Imbalance (TAI)
  • Large-Scale State Transitions (LST)
CGC 2022 Screen


Monday, Aug 1 from 6:15 PM - 7:45 PM (CT)
TitlePresenting Author
Peer-Reviewed Posters
Concordance of Integrated Analysis Approaches to Measure Genomic Instability Associated with Homologous Recombination Deficiency (HRD) Using TCGA Ovarian Cancer Dataset  Soheil Shams
Bionano Genomics
Use of Optical Genome Mapping and Next Generation Sequencing to Construct a Comprehensive Somatic Variation Map in a Cancer Cell LineAndy Pang
Bionano Genomics
Comparison of optical genome mapping, CMA, and 523-gene NGS panel for Homologous Recombination Deficiency calculation Nikhil Sahajpal
Augusta University
Optical Genome Mapping: Clinical Validation and Diagnostic Utility for Cytogenomic Analysis of Hematological Neoplasms Nikhil Sahajpal
Augusta University
Optical Genome Mapping Workflow for Identification and Analysis of Variants in Hematological MalignanciesJames Yu
Bionano Genomics
Optical Genome Mapping Workflow for Somatic Abnormality Detection in Multiple Solid Tumor TypesAlex Hastie
Bionano Genomics
Vendor-Presented Posters
Optical Genome Mapping Reveals Novel Structural Variants in Pediatric Brain Tumors Miriam Bornhorst
Children’s National Health System
Optical Genome Mapping for Somatic Abnormality Detection in Multiple Solid Tumor Types Benjamin Clifford
Bionano Genomics
Optical Genome Mapping: Unraveling the Genomic Landscape of Solitary Fibrous Tumor Enrique de Alava
IBiS, Spain
Optical Genome Mapping in Acute Myeloid Leukemia: A Multicenter Evaluation Brynn Levy
Columbia University
Optical Genome Mapping for Constitutional Postnatal SV, CNV, and Repeat Array Sizing: A Multi-site Clinical Study Nikhil Sahajpal
Augusta University
Optical Genome Mapping and NGS for Identification of All Classes of Variants James Yu
Bionano Genomics

Key publications in cancer research

A growing body of research demonstrates the benefits of optical genome mapping for cancer research. Check out some of the most recent publications from leading experts across the globe.
Next-generation cytogenetics: Comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping
Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping
Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients
The clinical utility of optical genome mapping for the assessment of genomic aberrations in acute lymphoblastic leukemia
Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias
Application of optical genome mapping for comprehensive assessment of chromosomal structural variants for clinical evaluation of myelodysplastic syndromes
A national multicenter evaluation of the clinical utility of optical genome mapping for assessment of genomic aberrations in acute myeloid leukemia
Solid Tumors
Identification of somatic structural variants in solid tumors by optical genome mapping
Optical genome mapping identifies a germline retrotransposon insertion in SMARCB1 in two siblings with atypical teratoid rhabdoid tumors
Multiplatform discovery and regulatory function analysis of structural variations in non-small cell lung carcinoma
Structure, dynamics, and impact of replication stress-induced structural variants in hepatocellular carcinoma
Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma
The landscape of extrachromosomal circular DNA in medulloblastoma

Stay Connected

Watch our social channels for more updates before, during, and after the event!

Contact Us


This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.